Effects of isradipine: A Synthesis of Findings from 26 Studies
- Home
- Effects of isradipine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of isradipine: A Synthesis of Findings from 26 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Isradipine is a calcium channel blocker that has been shown to be effective in treating hypertension. 13 found that isradipine was more effective in lowering blood pressure than prazosin. 6 found that isradipine reduced systolic and diastolic blood pressure in a dose-dependent manner. Isradipine is also effective in treating angina. 11 found that isradipine improved hemodynamics at rest and during exercise in patients with stable chronic angina. 9 found that isradipine was as effective as nifedipine in increasing exercise tolerance and reducing angina attacks. 20 found that isradipine and nifedipine had similar effects on angina frequency and severity. Isradipine has also been shown to have antiatherogenic properties in animal models of atherosclerosis. 14 suggests that isradipine may be effective in slowing the progression of atherosclerosis in humans.
A review of the cardiovascular effects of isradipine, 12 indicates that isradipine is a highly efficacious drug in monotherapy for hypertension and is well tolerated. Isradipine was found to have no clinically significant tachycardia or cardiodepressant effect, no fluid retention, and no orthostatic reactions.
Benefits and Risks
Benefit Summary
Isradipine is an effective treatment for hypertension and angina. It has also been shown to have antiatherogenic properties. It has also shown to be effective in reducing blood pressure in hypertensive patients treated with pindolol. 17 Isradipine may be a useful treatment for patients with exertional angina and hypertension, alone or associated with beta blocker medication. 3
Risk Summary
Isradipine is generally well tolerated, but it can cause side effects such as headache, dizziness, and flushing. 6 Isradipine can interact with other medications, so it is important to talk to your doctor about all the medications you are taking. 17 Isradipine may also cause a decrease in plasma beta-thromboglobulin levels, which may indicate a minor indirect effect on platelet function. 25 Isradipine may not be suitable for all patients, especially those with heart conditions. 11 Isradipine may not be effective in patients with chronic heart failure. 24
Comparison Across Studies
Commonalities Across Studies
Most studies have found that isradipine is effective in lowering blood pressure. Studies have also shown isradipine to be generally well tolerated.
Differences Across Studies
Some studies have found that isradipine is more effective than other calcium channel blockers or other antihypertensive drugs. 13 , 11 , 9 , 20 Other studies have found that isradipine is effective in treating angina. 11 , 9 , 20
Consistency and Discrepancies in Findings
There is some inconsistency in findings regarding the effects of isradipine on platelet function. Some studies suggest that isradipine may cause a minor indirect effect on platelet function, but this effect is not considered clinically significant. 25 More research is needed to understand the potential effects of isradipine on platelet function.
Notes on Applying Findings to Real Life
If you are considering using isradipine, it is important to talk to your doctor about your medical history and any other medications you are taking. Isradipine may not be appropriate for everyone, especially people with certain heart conditions. It is also important to note that the effects of isradipine may vary from person to person.
Limitations of Current Research
More research is needed to understand the long-term effects and safety of isradipine. Research is also needed to understand the potential interactions of isradipine with other medications. 17 Further research is also needed to understand the effectiveness of isradipine in treating chronic heart failure. 24
Future Directions for Research
Future research should focus on the long-term effects and safety of isradipine. It is also important to investigate the potential interactions of isradipine with other medications. Researchers should also investigate the potential benefits of isradipine in treating other cardiovascular conditions.
Conclusion
Isradipine appears to be a safe and effective treatment for hypertension and angina. 13 , 11 , 9 , 20 However, more research is needed to understand its long-term effects and safety. 24 If you are considering using isradipine, it is important to talk to your doctor about your medical history and any other medications you are taking.
Benefit Keywords
Risk Keywords
Article Type
Author: BurgerW, FuchsS, BurgerK J, KoberG
Language : English
Author: MeluzínJ, NovákM
Language : Czech
Author: DeloncaJ, KipferP, RighettiA
Language : English
Author: BorhaniN O, MillerS T, BruggerS B, SchnaperH W, CravenT E, BondM G, KhouryS, FlackJ
Language : English
Author: HolmesD, MoulletC
Language : English
Author: KirchW, BurgerK J, WeidingerG, WelzelD
Language : English
Author: KühlkampV, MaierF, SeipelL
Language : English
Author: Man in't VeldA J, HolmesD G, LasanceA, de ZwartP
Language : English
Author: CurrieP, SaltissiS
Language : English
Author: GrossP, KoppenhagenK, WudelE, BurgerK J, WelzelD, DistlerG A
Language : German
Author: MitrovicV, RieckmannC, KorneckiP, BurgerK J, WelzelD, SchlepperM
Language : English
Author: DahlöfB
Language : English
Author: SwartzS L, GonasunL M, McAllisterR G, ThadaniU
Language : English
Author: GrimmR H, FlackJ M, ByingtonR, BondG, BruggerS
Language : English
Author: StaessenJ, LijnenP, FagardR, HespelP, TanW P, DevosP, AmeryA
Language : English
Author: ShepherdA M, CarrA A, DavidovM, HamiltonJ, SchnaperH, VelasquezM, BrockwayB, PrisantL M, HamiltonB, GonasunL
Language : English
Author: FrithzG, AströmB, DahlöfB, HanssonL, TollinC, HimanenP, SundstedtC D
Language : English
Author: RupoliL, FruscioM, GradnikR, ChiancaR, LeonettiG, ZanchettiA
Language : English
Author: BurgerW, NeidelS, KoberG
Language : English
Author: HandlerC E, RosenthalE, TsagadopoulosD, NajmY
Language : English
Author: ThadaniU, ChrysantS, GorwitJ, GilesT, ArcherS, IteldB, SinghS, CopenD, WakefordC, HobbsS
Language : English
Author: TulloN G, LandauS, GoldmanI, CoutinhoN, SombergJ
Language : English
Author: DoatM, HacotJ P, PavinD, RighettiA
Language : English
Author: van den TorenE W, van VeldhuisenD J, van BruggenA, van den BroekS A, van GilstW H, LieK I
Language : English
Author: SmithA, McPhersonJ, TaylorM, MasonA, CarneyS, GilliesA
Language : English
Author: ByingtonR P, FurbergC D, CravenT E, PahorM, SowersJ R
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.